Adverse events35

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 35

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hot flashes	Endocrine disorders	Group 1: Control	0	53	0
other	Hot flashes	Endocrine disorders	Group 2: Raloxifene 60 mg	10	53	10
other	Hot flashes	Endocrine disorders	Group 3: Raloxifene 30 mg	7	53	7
other	Hot flashes	Endocrine disorders	Group 4: Lovaza 4 gm	0	54	0
other	Hot flashes	Endocrine disorders	Group 5: Lovaza 4 gm and Raloxifene 30 mg	6	53	6
other	Night Sweating (diaphoresis)	General disorders	Group 1: Control	0	53	0
other	Night Sweating (diaphoresis)	General disorders	Group 2: Raloxifene 60 mg	6	53	6
other	Night Sweating (diaphoresis)	General disorders	Group 3: Raloxifene 30 mg	3	53	3
other	Night Sweating (diaphoresis)	General disorders	Group 4: Lovaza 4 gm	0	54	0
other	Night Sweating (diaphoresis)	General disorders	Group 5: Lovaza 4 gm and Raloxifene 30 mg	2	53	2
other	Rosacea	Skin and subcutaneous tissue disorders	Group 1: Control	1	53	1
other	Rosacea	Skin and subcutaneous tissue disorders	Group 2: Raloxifene 60 mg	2	53	2
other	Rosacea	Skin and subcutaneous tissue disorders	Group 3: Raloxifene 30 mg	0	53	0
other	Rosacea	Skin and subcutaneous tissue disorders	Group 4: Lovaza 4 gm	0	54	0
other	Rosacea	Skin and subcutaneous tissue disorders	Group 5: Lovaza 4 gm and Raloxifene 30 mg	1	53	1
other	Vaginal Spotting	Reproductive system and breast disorders	Group 1: Control	0	53	0
other	Vaginal Spotting	Reproductive system and breast disorders	Group 2: Raloxifene 60 mg	2	53	2
other	Vaginal Spotting	Reproductive system and breast disorders	Group 3: Raloxifene 30 mg	0	53	0
other	Vaginal Spotting	Reproductive system and breast disorders	Group 4: Lovaza 4 gm	0	54	0
other	Vaginal Spotting	Reproductive system and breast disorders	Group 5: Lovaza 4 gm and Raloxifene 30 mg	1	53	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00723398/events

API reference For AI assistants

Adverse events35

Sources 3

Read this list from software.